Discontinuation of hydroxychloroquine in older patients with systemic lupus erythematosus: a multicenter retrospective study

Abstract Background Although hydroxychloroquine (HCQ) is a mainstay of treatment for patients with systemic lupus erythematosus (SLE), ocular toxicity can result from accumulated exposure. As the longevity of patients with SLE improves, data are needed to balance the risk of ocular toxicity and the...

Cijeli opis

Bibliografski detalji

Glavni autori:	Ruth Fernandez-Ruiz, Nicole Bornkamp, Mimi Y. Kim, Anca Askanase, Anna Zezon, Chung-E Tseng, H. Michael Belmont, Amit Saxena, Jane E. Salmon, Michael Lockshin, Jill P. Buyon, Peter M. Izmirly
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2020-08-01
Serija:	Arthritis Research & Therapy
Teme:	Lupus Hydroxychloroquine Maculopathy
Online pristup:	http://link.springer.com/article/10.1186/s13075-020-02282-0
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!